Loading data
XLABNasdaq
| Unit: USD | FY2026 | FY2025 |
|---|---|---|
| Revenue | 14.82 m USD | 7.02 m USD |
| Cost of revenue | 12.4 m USD | 5.91 m USD |
| Gross profit | 2.42 m USD | 1.11 m USD |
| Research and development expense | 5.49 m USD | 2.8 m USD |
| Operating profit | -4.8 m USD | -3.04 m USD |
| Profit before tax | -12.16 m USD | -7.66 m USD |
| Net income (reported basis) | -12.16 m USD | -7.66 m USD |
| Net income attributable to common shareholders | -12.16 m USD | -7.66 m USD |
| Basic earnings per share | -8,108.26 USD/share | -5,106.44 USD/share |
| Diluted earnings per share | -8,108.26 USD/share | -5,106.44 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.